Literature DB >> 15080268

Circulating interleukin 17 is increased in the acute stage of Kawasaki disease.

M H Sohn1, S Y Noh, W Chang, K M Shin, D S Kim.   

Abstract

OBJECTIVES: During the acute phase, patients with Kawasaki disease (KD), an acute systemic vasculitis, demonstrate a drastic increase in serum interleukin-6 (IL-6), which parallels the duration of the fever. Recently, IL-17 has been reported to induce IL-6 production. The aim of this study was to elucidate the involvement of IL-17 in the pathogenesis of KD.
METHODS: Serum samples were obtained from patients with KD (n=30) and normal controls (n=20), and the concentrations of IL-17 and IL-6 measured using enzyme-linked immunosorbent assay (ELISA).
RESULTS: Compared with the normal controls (2.08 +/- 2.14 pg/mL), serum IL-17 was markedly elevated in patients with acute KD (25.47 +/- 5.05 pg/mL): levels gradually decreased in the subacute phase (5.94 +/- 2.83 pg/mL). In the acute phase, levels of IL-6 were 83.52 +/- 19.12 pg/L, which correlated well with the serum levels of IL-17.
CONCLUSION: These results suggest that IL-17 may be involved in the development of, or the effects of inflammation in KD.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15080268     DOI: 10.1080/03009740410005034

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  12 in total

1.  A genome-wide association study identifies three new risk loci for Kawasaki disease.

Authors:  Yoshihiro Onouchi; Kouichi Ozaki; Jane C Burns; Chisato Shimizu; Masaru Terai; Hiromichi Hamada; Takafumi Honda; Hiroyuki Suzuki; Tomohiro Suenaga; Takashi Takeuchi; Norishige Yoshikawa; Yoichi Suzuki; Kumi Yasukawa; Ryota Ebata; Kouji Higashi; Tsutomu Saji; Yasushi Kemmotsu; Shinichi Takatsuki; Kazunobu Ouchi; Fumio Kishi; Tetsushi Yoshikawa; Toshiro Nagai; Kunihiro Hamamoto; Yoshitake Sato; Akihito Honda; Hironobu Kobayashi; Junichi Sato; Shoichi Shibuta; Masakazu Miyawaki; Ko Oishi; Hironobu Yamaga; Noriyuki Aoyagi; Seiji Iwahashi; Ritsuko Miyashita; Yuji Murata; Kumiko Sasago; Atsushi Takahashi; Naoyuki Kamatani; Michiaki Kubo; Tatsuhiko Tsunoda; Akira Hata; Yusuke Nakamura; Toshihiro Tanaka
Journal:  Nat Genet       Date:  2012-03-25       Impact factor: 38.330

Review 2.  Interleukin 17 in vascular inflammation.

Authors:  Sibylle von Vietinghoff; Klaus Ley
Journal:  Cytokine Growth Factor Rev       Date:  2010-11-12       Impact factor: 7.638

3.  CD4+ T cells sensitized by vascular smooth muscle induce vasculitis, and interferon gamma is critical for the initiation of vascular pathology.

Authors:  Dana Carina Baiu; Matyas Sandor; Michael Hart
Journal:  Am J Pathol       Date:  2010-10-22       Impact factor: 4.307

4.  Increased frequency of immunoglobulin (Ig)A-secreting cells following Toll-like receptor (TLR)-9 engagement in patients with Kawasaki disease.

Authors:  L Giordani; M G Quaranta; A Marchesi; E Straface; D Pietraforte; A Villani; W Malorni; D Del Principe; M Viora
Journal:  Clin Exp Immunol       Date:  2010-12-22       Impact factor: 4.330

5.  The epidemiology of Kawasaki disease in an urban hospital: does African American race protect against coronary artery aneurysms?

Authors:  A R Porcalla; C A Sable; K M Patel; G R Martin; N Singh
Journal:  Pediatr Cardiol       Date:  2005 Nov-Dec       Impact factor: 1.655

6.  The T helper type 17/regulatory T cell imbalance in patients with acute Kawasaki disease.

Authors:  S Jia; C Li; G Wang; J Yang; Y Zu
Journal:  Clin Exp Immunol       Date:  2010-08-16       Impact factor: 4.330

Review 7.  Kawasaki disease.

Authors:  Dong Soo Kim
Journal:  Yonsei Med J       Date:  2006-12-31       Impact factor: 2.759

8.  IL-17 and TNF-α sustain neutrophil recruitment during inflammation through synergistic effects on endothelial activation.

Authors:  Gabriel K Griffin; Gail Newton; Margarite L Tarrio; De-xiu Bu; Elena Maganto-Garcia; Veronica Azcutia; Pilar Alcaide; Nir Grabie; Francis W Luscinskas; Kevin J Croce; Andrew H Lichtman
Journal:  J Immunol       Date:  2012-05-07       Impact factor: 5.422

9.  Elevated Serum Levels of IL-21 in Kawasaki Disease.

Authors:  Yon Jung Bae; Mi Hyun Kim; Hae Yong Lee; Young Uh; Mee Kyung Namgoong; Byung Ho Cha; Jin-Kyong Chun
Journal:  Allergy Asthma Immunol Res       Date:  2012-06-29       Impact factor: 5.764

10.  Important role of CCR2 in a murine model of coronary vasculitis.

Authors:  Hernan G Martinez; Marlon P Quinones; Fabio Jimenez; Carlos Estrada; Kassandra M Clark; Kazuo Suzuki; Noriko Miura; Naohito Ohno; Sunil K Ahuja; Seema S Ahuja
Journal:  BMC Immunol       Date:  2012-10-17       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.